LANCHONEY DIANA M 4
4 · Diffusion Pharmaceuticals Inc. · Filed Jul 5, 2023
Insider Transaction Report
Form 4
LANCHONEY DIANA M
Director
Transactions
- Exercise/Conversion
Restricted Stock Unit
2023-06-30−232→ 928 total→ Common Stock (232 underlying) - Exercise/Conversion
Common Stock
2023-06-30+232→ 379 total - Disposition to Issuer
Common Stock
2023-06-30−85→ 294 total
Footnotes (1)
- [F1]On March 31, 2023 (the "Vesting Date"), in connection with the vesting of previously awarded restricted stock units ("RSUs"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a "Share"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the "Plan") and the terms of the underlying award agreement, (i) 147 Shares and (ii) $283.90 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $3.34. The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer.